Navigation Links
New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
Date:10/21/2009

ance.

About Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low-Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO(2) and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET® Pulse CO-Oximetry(TM), a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and PVI(TM), in addition to oxyhemoglobin (SpO(2)), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectatio
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... March 31, 2015.  The net loss and the loss ... and $13.0 million, respectively, compared to $10.7 million and ...  At March 31, 2015, Alexza had consolidated cash, cash ... "We continue to focus on ways in ...
(Date:5/6/2015)... 2015  Integrative medicine interventions lead to significant ... chronic pain, depression, and stress, according to ... Bravewell Collaborative . The findings are based on ... Interventions Effectiveness Registry (PRIMIER), the first-ever patient registry ... PRIMIER , researchers found that the use ...
(Date:5/6/2015)... CVS Health (NYSE: CVS ) officially announced today ... locations that sustained heavy fire damage during protests last week.  ... over the past week or so, our hearts turned ... Health President and CEO Larry Merlo . "Our purpose as ... There is no better way that we can fulfill that purpose ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2
... Jan. 3, 2011 Bacterin International Holdings, Inc. ... that it is scheduled to present at the upcoming OneMedForumSF ... at 8:30 a.m. (PT) at the Sir Francis Drake Hotel ... of Bacterin will present the Company,s operations and its strategic ...
... SRI International, an independent nonprofit research and development organization, ... Sarnoff Corporation, its wholly owned subsidiary in Princeton, New ... welcome our new colleagues to SRI and celebrate their ... Carlson, Ph.D., president and CEO of SRI International. "Together, ...
Cached Medicine Technology:Bacterin International Holdings to Present at the OneMedForum San Francisco 2011 2Bacterin International Holdings to Present at the OneMedForum San Francisco 2011 3
(Date:5/6/2015)... May 06, 2015 Inversion Studios, ... in yoga and Pilates classes, provides personalized individual ... products, starting with its new Pilates Ring magic ... of becoming leaner, stronger, more centered and graceful, ... a fresh venue to healthy fitness through yoga ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Vancouver ... recently shared their new blog containing the Canadian ... by the Canadian Society for Exercise Physiology (CSEP). ... physical activity, health and fitness research and personal ... and exercise are highly beneficial and a rich ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Anitoa Systems, ... partnering with Zhejiang University of China, has successfully demonstrated ... ultra-low-light CMOS bio-optical sensor. Anitoa’s handheld qPCR is ... pathogen DNA and RNA’s, including hepatitis B, C, and ... of 4 copies per sample and over 9 orders ...
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive Detroit as ... the headlines of major publications world-wide. With 150+ speakers ... ready to share their visions for the future of ... press to go behind the scenes and hear major ... “This year we’re releasing a preview of all the ...
(Date:5/6/2015)... WASHINGTON, DC (PRWEB) May 06, 2015 ... international organization representing the regenerative medicine and advanced ... first-ever quarterly data report, offering an in-depth look ... January through March 2015. , The report is ... standalone graphics highlighting key data points, available ...
Breaking Medicine News(10 mins):Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... The Environment and Health & Beauty Get a ... 3 HowToDoThings.com, a,popular online destination that helps ... instruction on diverse topics, celebrates the,world,s most popular ... coffee, in recognition of "Caffeine Awareness Month" in ...
... American Cancer Society, (http://www.cancer.org ) lists March 2008 ... the onset of colon cancer. According to the ... cases are discovered,annually...deaths from Colon and Rectal Cancer ... either avoid Colon Cancer or detect,tumors earlier than ...
... Scotland, March 3 Aircraft Medical, the UK,medical ... sponsoring the,prestigious 14th World Congress of Anaesthesiologists (the ... Draeger. Held every four,years, the WCA is the ... is Aircraft Medical sponsoring the event, but the ...
... same doctor during their first six months of life ... -- for lead poisoning, anemia and tuberculosis -- by ... by the same physician, often referred to as continuity ... children they studied. , Researchers from The Children,s Hospital ...
... Corporation of,North America, its U.S. subsidiary, MGI PHARMA, ... U.S. Food and Drug Administration,(FDA) has approved Aloxi(R) ... and vomiting (PONV) for up to 24 hours,following ... demonstrated., Aloxi, available in the United States ...
... cells may provide an explanation for the cause of ... causes premature aging in children, according to researchers at ... Institutes of Health (NIH). These findings, the first ... of HGPS, also known as progeria, may also provide ...
Cached Medicine News:Health News:HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of March's 'Caffeine Awareness Month' 2Health News:SGV Medical Supplies: 'Colostomy Supplies Easier to Obtain for the Colon Cancer Survivor' 2Health News:Aircraft Medical to Sponsor World's Premier Anaesthesiology Conference 2Health News:In early childhood, continuous care by 1 doctor improves delivery of health screenings 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 3Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 4Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 5Health News:Adult stem cell changes underlie rare genetic disease associated with accelerated aging 2
... importance of electronic connectivity for ... understood. Transmission of patient results ... records, and billing. A sound ... connectivity is essential to ensure ...
248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
... Discovery 90SE Ultracentrifuge offers ... discover more. All the ... top-of-the-line performance, powerful functionality, ... use, all built into ...
... g-force ever. But optimal productivity in the ... combines maximum force, capacity, and ease of ... apart from any other system. With advanced ... Optima takes productivity to the MAX. Optima ...
Medicine Products: